Colorectal cancer cells - Proliferation, survival and invasion by lysophosphatidic acid

International Journal of Biochemistry and Cell Biology

Volumn 42, Issue 12, 2010, Pages 1907-1910

  Lee, Sei Jung ^a   Yun, C Chris ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Colorectal cancer; G protein coupled receptor; Phospholipids

Indexed keywords

G PROTEIN COUPLED RECEPTOR; LYSOPHOSPHATIDIC ACID; LYSOPHOSPHATIDIC ACID RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR;

ANGIOGENESIS; CANCER CELL; CANCER GROWTH; CANCER INVASION; CELL INVASION; CELL PROLIFERATION; CELL SURVIVAL; COLON ADENOCARCINOMA; COLORECTAL CANCER; CYTOKINE PRODUCTION; DNA MODIFICATION; ENZYME ACTIVATION; GENE MUTATION; GENE TARGETING; HUMAN; NONHUMAN; PROTEIN EXPRESSION; SHORT SURVEY; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

CELL GROWTH PROCESSES; CELL SURVIVAL; COLORECTAL NEOPLASMS; HUMANS; LYSOPHOSPHOLIPIDS; NEOPLASM INVASIVENESS; RECEPTORS, LYSOPHOSPHATIDIC ACID; SIGNAL TRANSDUCTION;

EID: 78149285909     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biocel.2010.09.021     Document Type: Short Survey

References (34)

1. Barker N., Ridgway R.A., van Es J.H., van de Wetering M., Begthel H., van den Born M., et al. Crypt stem cells as the cells-of-origin of intestinal cancer. Nature 2009, 457:608-611.
2. Choi J.W., Lim S., Oh Y.S., Kim E.K., Kim S.H., Kim Y.H., et al. Subtype-specific role of phospholipase C-beta in bradykinin and LPA signaling through differential binding of different PDZ scaffold proteins. Cell Signal 2010, 22:1153-1161.
3. Deng W., Shuyu E., Tsukahara R., Valentine W.J., Durgam G., Gududuru V., et al. The lysophosphatidic acid type 2 receptor is required for protection against radiation-induced intestinal injury. Gastroenterology 2007, 132:1834-1851.
4. Deng W., Wang D.A., Gosmanova E., Johnson L.R., Tigyi G. LPA protects intestinal epithelial cells from apoptosis by inhibiting the mitochondrial pathway. Am J Physiol 2003, 284:G821-G829.
5. Dorsam R.T., Gutkind J.S. G-protein-coupled receptors and cancer. Nat Rev Cancer 2007, 7:79-94.
6. Fearon E.R., Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990, 61:759-767.
7. Goetzl E.J., Dolezalova H., Kong Y., Hu Y.L., Jaffe R.B., Kalli K.R., et al. Distinctive expression and functions of the type 4 endothelial differentiation gene-encoded G protein-coupled receptor for lysophosphatidic acid in ovarian cancer. Cancer Res 1999, 59:5370-5375.
8. Hines O.J., Ryder N., Chu J., McFadden D. Lysophosphatidic acid stimulates intestinal restitution via cytoskeletal activation and remodeling. J Surg Res 2000, 92:23-28.
9. Khurana S., Tomar A., George S.P., Wang Y., Siddiqui M.R., Guo H., et al. Autotaxin and lysophosphatidic acid stimulate intestinal cell motility by redistribution of the actin modifying protein villin to the developing lamellipodia. Exp Cell Res 2008, 314:530-542.
10. Kinzler K.W., Vogelstein B. Lessons from hereditary colorectal cancer. Cell 1996, 87:159-170.
11. Lee J., Park S.Y., Lee E.K., Park C.G., Chung H.C., Rha S.Y., et al. Activation of hypoxia-inducible factor-1alpha is necessary for lysophosphatidic acid-induced vascular endothelial growth factor expression. Clin Cancer Res 2006, 12:6351-6358.
12. Li C., Dandridge K.S., Di A., Marrs K.L., Harris E.L., Roy K., et al. Lysophosphatidic acid inhibits cholera toxin-induced secretory diarrhea through CFTR-dependent protein interactions. J Exp Med 2005, 202:975-986.
13. Lin F.T., Lai Y.J. Regulation of the LPA2 receptor signaling through the carboxyl-terminal tail-mediated protein-protein interactions. Biochim Biophys Acta 2008, 1781:558-562.
14. Lin S., Wang D., Iyer S., Ghaleb A.M., Shim H., Yang V.W., et al. The absence of LPA2 attenuates tumor formation in an experimental model of colitis-associated cancer. Gastroenterology 2009, 136:1711-1720.
15. 5 and NHERF2. Gastroenterology 2010, 138:649-658.
16. Liu S., Umezu-Goto M., Murph M., Lu Y., Liu W., Zhang F., et al. Expression of autotaxin and lysophosphatidic acid receptors increases mammary tumorigenesis, invasion, and metastases. Cancer Cell 2009, 15:539-550.
17. Markowitz S.D., Bertagnolli M.M. Molecular origins of cancer: molecular basis of colorectal cancer. N Engl J Med 2009, 361:2449-2460.
18. McConnell B.B., Bialkowska A.B., Nandan M.O., Ghaleb A.M., Gordon F.J., Yang V.W. Haploinsufficiency of Kruppel-like factor 5 rescues the tumor-initiating effect of the Apc(Min) mutation in the intestine. Cancer Res 2009, 69:4125-4133.
19. Oh Y.S., Jo N.W., Choi J.W., Kim H.S., Seo S.W., Kang K.O., et al. NHERF2 specifically interacts with LPA2 receptor and defines the specificity and efficiency of receptor-mediated phospholipase C-β3 activation. Mol Cell Biol 2004, 24:5069-5079.
20. Preston S.L., Wong W.-M., Chan A.O.-O., Poulsom R., Jeffery R., Goodlad R.A., et al. Bottom-up histogenesis of colorectal adenomas. Cancer Res 2003, 63:3819-3825.
21. Rhodes J.M., Campbell B.J. Inflammation and colorectal cancer: IBD-associated and sporadic cancer compared. Trends Mol Med 2002, 8:10-16.
22. Rusovici R., Ghaleb A., Shim H., Yang V.W., Yun C.C. Lysophosphatidic acid prevents apoptosis of Caco-2 colon cancer cells via activation of mitogen-activated protein kinase and phosphorylation of Bad. Biochim Biophys Acta 2007, 1770:1194-1203.
23. Sancho E., Batlle E., Clevers H. Signaling pathways in intestinal development and cancer. Annu Rev Cell Dev Biol 2004, 20:695-723.
24. Shida D., Kitayama J., Yamaguchi H., Okaji Y., Tsuno N.H., Watanabe T., et al. Lysophosphatidic acid (LPA) enhances the metastatic potential of human colon carcinoma DLD1 cells through LPA1. Cancer Res 2003, 63:1706-1711.
25. Shida D., Watanabe T., Aoki J., Hama K., Kitayama J., Sonoda H., et al. Aberrant expression of lysophosphatidic acid (LPA) receptors in human colorectal cancer. Lab Invest 2004, 84:1352-1362.
26. Shih I.M., Wang T.L., Traverso G., Romans K., Hamilton S.R., Ben-Sasson S., et al. Top-down morphogenesis of colorectal tumors. Proc Natl Acad Sci USA 2001, 98:2640-2645.
27. Sturm A., Sudermann T., Schulte K.M., Goebell H., Dignass A.U. Modulation of intestinal epithelial wound healing in vitro and in vivo by lysophosphatidic acid. Gastroenterology 1999, 117:368-377.
28. van Meeteren L.A., Moolenaar W.H. Regulation and biological activities of the autotaxin-LPA axis. Prog Lipid Res 2007, 46:145-160.
29. Xu Y., Shen Z., Wiper D.W., Wu M., Morton R.E., Elson P., et al. Lysophosphatidic acid as a potential biomarker for ovarian and other gynecologic cancers. JAMA 1998, 280:719-723.
30. Yamada T., Ohoka Y., Kogo M., Inagaki S. Physical and functional interactions of the lysophosphatidic acid receptors with PDZ domain-containing Rho guanine nucleotide exchange factors (RhoGEFs). J Biol Chem 2005, 280:19358-19363.
31. Yang M., Zhong W.W., Srivastava N., Slavin A., Yang J., Hoey T., et al. G protein-coupled lysophosphatidic acid receptors stimulate proliferation of colon cancer cells through the β-catenin pathway. Proc Natl Acad Sci USA 2005, 102:6027-6032.
32. Yun C.C., Sun H., Wang D., Rusovici R., Castleberry A., Hall R.A., et al. LPA2 receptor mediates mitogenic signals in human colon cancer cells. Am J Physiol Cell Physiol 2005, 289:C2-C11.
33. Zhang H., Bialkowska A., Rusovici R., Chanchevalap S., Shim H., Katz J.P., et al. Lysophosphatidic acid facilitates proliferation of colon cancer cells via induction of Kruppel-like factor 5. J Biol Chem 2007, 282:15541-15549.
34. Zhang H., Wang D., Sun H., Hall R.A., Yun C.C. MAGI-3 regulates LPA-induced activation of Erk and RhoA. Cell Signal 2007, 19:261-268.